{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T04:03:02Z","timestamp":1793678582602,"version":"4.5.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T00:00:00Z","timestamp":1696982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T00:00:00Z","timestamp":1696982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81622018"],"award-info":[{"award-number":["81622018"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072096"],"award-info":[{"award-number":["82072096"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cognitive impairment is a core feature of schizophrenia, which is aggravated by antipsychotics-induced metabolic disturbance and lacks effective pharmacologic treatments in clinical practice. Our previous study demonstrated the efficiency of metformin in alleviating metabolic disturbance following antipsychotic administration. Here we report that metformin could ameliorate cognitive impairment and improve functional connectivity (FC) in prefrontal regions. This is an open-labeled, evaluator-blinded study. Clinically stable patients with schizophrenia were randomly assigned to receive antipsychotics plus metformin (<jats:italic>N<\/jats:italic>\u2009=\u200948) or antipsychotics alone (<jats:italic>N<\/jats:italic>\u2009=\u200924) for 24 weeks. The improvement in cognition was assessed by the MATRICS Consensus Cognitive Battery (MCCB). Its association with metabolic measurements, and voxel-wise whole-brain FC with dorsolateral prefrontal cortex (DLPFC) subregions as seeds were evaluated. When compared to the antipsychotics alone group, the addition of metformin resulted in significantly greater improvements in the MCCB composite score, speed of processing, working memory, verbal learning, and visual learning. A significant time\u2009\u00d7\u2009group interaction effect of increased FC between DLPFC and the anterior cingulate cortex (ACC)\/middle cingulate cortex (MCC), and between DLPFC subregions were observed after metformin treatment, which was positively correlated with MCCB cognitive performance. Furthermore, the FC between left DLPFC A9\/46d to right ACC\/MCC significantly mediated metformin-induced speed of processing improvement; the FC between left A46 to right ACC significantly mediated metformin-induced verbal learning improvement. Collectively, these findings demonstrate that metformin can improve cognitive impairments in schizophrenia patients and is partly related to the FC changes in the DLPFC. Trial Registration: The trial was registered with ClinicalTrials.gov (NCT03271866). The full trial protocol is provided in Supplementary Material.<\/jats:p>","DOI":"10.1038\/s41398-023-02616-x","type":"journal-article","created":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T08:06:59Z","timestamp":1697011619000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Metformin improves cognitive impairment in patients with schizophrenia: associated with enhanced functional connectivity of dorsolateral prefrontal cortex"],"prefix":"10.1038","volume":"13","author":[{"given":"Tiannan","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gangrui","family":"Hei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyu","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangkun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2029-5187","authenticated-orcid":false,"given":"Bing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0510-715X","authenticated-orcid":false,"given":"Ti-Fei","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1758-4738","authenticated-orcid":false,"given":"Renrong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,11]]},"reference":[{"key":"2616_CR1","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S2215-0366(20)30513-7","volume":"8","author":"WW Fleischhacker","year":"2021","unstructured":"Fleischhacker WW, Podhorna J, Gr\u00f6schl M, Hake S, Zhao Y, Huang S, et al. Efficacy and safety of the novel glycine transporter inhibitor BI 425809 once daily in patients with schizophrenia: a double-blind, randomised, placebo-controlled phase 2 study. Lancet Psychiatry. 2021;8:191\u2013201.","journal-title":"Lancet Psychiatry"},{"key":"2616_CR2","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/wps.20624","volume":"18","author":"MF Green","year":"2019","unstructured":"Green MF, Horan WP, Lee JJWP. Nonsocial and social cognition in schizophrenia: current evidence and future directions. World Psychiatry. 2019;18:146\u201361.","journal-title":"World Psychiatry"},{"key":"2616_CR3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.schres.2004.09.009","volume":"72","author":"MF Green","year":"2004","unstructured":"Green MF, Kern RS, Heaton RK. Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophr Res. 2004;72:41\u201351.","journal-title":"Schizophr Res"},{"key":"2616_CR4","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1001\/jamapsychiatry.2021.0015","volume":"78","author":"K Hagi","year":"2021","unstructured":"Hagi K, Nosaka T, Dickinson D, Lindenmayer JP, Lee J, Friedman J, et al. Association between cardiovascular risk factors and cognitive impairment in people with Schizophrenia: a systematic review and meta-analysis. JAMA Psychiatry. 2021;78:510\u201318.","journal-title":"JAMA Psychiatry"},{"key":"2616_CR5","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.psychres.2019.05.023","volume":"278","author":"S Grover","year":"2019","unstructured":"Grover S, R P, Sahoo S, Gopal S, Nehra R, Ganesh A, et al. Relationship of metabolic syndrome and neurocognitive deficits in patients with schizophrenia. Psychiatry Res. 2019;278:56\u201364.","journal-title":"Psychiatry Res"},{"key":"2616_CR6","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/0033354919893030","volume":"135","author":"ML Adams","year":"2020","unstructured":"Adams ML, Grandpre J, Katz DL, Shenson D. Cognitive impairment and cardiovascular disease: a comparison of risk factors, disability, quality of life, and access to health care. Public Health Rep. 2020;135:132\u201340.","journal-title":"Public Health Rep."},{"key":"2616_CR7","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/wps.20069","volume":"12","author":"D Vancampfort","year":"2013","unstructured":"Vancampfort D, Wampers M, Mitchell AJ, Correll CU, De Herdt A, Probst M, et al. A meta-analysis of cardio-metabolic abnormalities in drug na\u00efve, first-episode and multi-episode patients with schizophrenia versus general population controls. World Psychiatry. 2013;12:240\u201350.","journal-title":"World Psychiatry"},{"key":"2616_CR8","first-page":"185","volume":"299","author":"R-R Wu","year":"2008","unstructured":"Wu R-R, Zhao J-P, Jin H, Shao P, Fang M-S, Guo X-F, et al. Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized controlled trial. JAMA. 2008;299:185\u201393.","journal-title":"JAMA"},{"key":"2616_CR9","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/mp.2015.221","volume":"21","author":"R Wu","year":"2016","unstructured":"Wu R, Zhang F, Gao K, Ou J, Shao P, Jin H, et al. Metformin treatment of antipsychotic-induced dyslipidemia: an analysis of two randomized, placebo-controlled trials. Mol Psychiatry. 2016;21:1537.","journal-title":"Mol Psychiatry"},{"key":"2616_CR10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3109\/15622975.2012.739708","volume":"14","author":"A Hasan","year":"2013","unstructured":"Hasan A, Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz WF, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects. World J Biol Psychiatry. 2013;14:2\u201344.","journal-title":"World J Biol Psychiatry"},{"key":"2616_CR11","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S1734-1140(10)70357-1","volume":"62","author":"K \u0141abuzek","year":"2010","unstructured":"\u0141abuzek K, Suchy D, Gabryel B, Bielecka A, Liber S, Okopie\u0144 B. Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide. Pharmacol Rep. 2010;62:956\u201365.","journal-title":"Pharmacol Rep."},{"key":"2616_CR12","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/s41591-020-0985-2","volume":"26","author":"R Ayoub","year":"2020","unstructured":"Ayoub R, Ruddy RM, Cox E, Oyefiade A, Derkach D, Laughlin S, et al. Assessment of cognitive and neural recovery in survivors of pediatric brain tumors in a pilot clinical trial using metformin. Nat Med. 2020;26:1285\u201394.","journal-title":"Nat Med"},{"key":"2616_CR13","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/1440-1681.12265","volume":"41","author":"M Guo","year":"2014","unstructured":"Guo M, Mi J, Jiang QM, Xu JM, Tang YY, Tian G, et al. Metformin may produce antidepressant effects through improvement of cognitive function among depressed patients with diabetes mellitus. Clin Exp Pharm Physiol. 2014;41:650\u20136.","journal-title":"Clin Exp Pharm Physiol"},{"key":"2616_CR14","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3233\/JAD-150493","volume":"51","author":"JA Luchsinger","year":"2016","unstructured":"Luchsinger JA, Perez T, Chang H, Mehta P, Steffener J, Pradabhan G, et al. Metformin in amnestic mild cognitive impairment: results of a pilot randomized placebo controlled clinical trial. J Alzheimers Dis. 2016;51:501\u201314.","journal-title":"J Alzheimers Dis"},{"key":"2616_CR15","doi-asserted-by":"crossref","first-page":"5715","DOI":"10.1007\/s12035-017-0752-7","volume":"55","author":"YK Ryu","year":"2018","unstructured":"Ryu YK, Park HY, Go J, Choi DH, Kim YH, Hwang JH, et al. Metformin Inhibits the development of L-DOPA-induced Dyskinesia in a murine model of parkinson\u2019s disease. Mol Neurobiol. 2018;55:5715\u201326.","journal-title":"Mol Neurobiol"},{"key":"2616_CR16","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-021-01338-2","volume":"11","author":"SM Agarwal","year":"2021","unstructured":"Agarwal SM, Panda R, Costa-Dookhan KA, MacKenzie NE, Treen QC, Caravaggio F, et al. Metformin for early comorbid glucose dysregulation and schizophrenia spectrum disorders: a pilot double-blind randomized clinical trial. Transl Psychiatry. 2021;11:219.","journal-title":"Transl Psychiatry"},{"key":"2616_CR17","volume":"10","author":"R Tao","year":"2020","unstructured":"Tao R, Li C, Jaffe AE, Shin JH, Deep-Soboslay A, Yamin R, et al. Cannabinoid receptor CNR1 expression and DNA methylation in human prefrontal cortex, hippocampus and caudate in brain development and schizophrenia. Transl Psychiatry. 2020;10:158.","journal-title":"Transl Psychiatry"},{"key":"2616_CR18","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1038\/mp.2017.105","volume":"23","author":"R Tao","year":"2018","unstructured":"Tao R, Davis KN, Li C, Shin JH, Gao Y, Jaffe AE, et al. GAD1 alternative transcripts and DNA methylation in human prefrontal cortex and hippocampus in brain development, schizophrenia. Mol Psychiatry. 2018;23:1496\u2013505.","journal-title":"Mol Psychiatry"},{"key":"2616_CR19","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1176\/appi.ajp.2008.07060945","volume":"165","author":"JH Yoon","year":"2008","unstructured":"Yoon JH, Minzenberg MJ, Ursu S, Ryan Walter BS, Wendelken C, et al. Association of dorsolateral prefrontal cortex dysfunction with disrupted coordinated brain activity in schizophrenia: relationship with impaired cognition, behavioral disorganization, and global function. Am J Psychiatry. 2008;165:1006\u201314.","journal-title":"Am J Psychiatry"},{"key":"2616_CR20","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.pscychresns.2006.11.008","volume":"154","author":"DH Wolf","year":"2007","unstructured":"Wolf DH, Gur RC, Valdez JN, Loughead J, Elliott MA, Gur RE, et al. Alterations of fronto-temporal connectivity during word encoding in schizophrenia. Psychiatry Res. 2007;154:221\u201332.","journal-title":"Psychiatry Res"},{"key":"2616_CR21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.nicl.2017.05.001","volume":"15","author":"KL Ray","year":"2017","unstructured":"Ray KL, Lesh TA, Howell AM, Salo TP, Ragland JD, MacDonald AW, et al. Functional network changes and cognitive control in schizophrenia. Neuroimage Clin. 2017;15:161\u201370.","journal-title":"Neuroimage Clin"},{"key":"2616_CR22","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.biopsych.2011.02.019","volume":"70","author":"A Fornito","year":"2011","unstructured":"Fornito A, Yoon J, Zalesky A, Bullmore ET, Carter CS. General and specific functional connectivity disturbances in first-episode schizophrenia during cognitive control performance. Biol Psychiatry. 2011;70:64\u201372.","journal-title":"Biol Psychiatry"},{"key":"2616_CR23","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1093\/schbul\/sbq038","volume":"37","author":"RW Buchanan","year":"2011","unstructured":"Buchanan RW, Keefe RS, Umbricht D, Green MF, Laughren T, Marder SRJSB. The FDA-NIMH-MATRICS guidelines for clinical trial design of cognitive-enhancing drugs: what do we know 5 years later? Schizophr Bull. 2011;37:1209\u201317.","journal-title":"Schizophr Bull"},{"key":"2616_CR24","doi-asserted-by":"crossref","first-page":"e424","DOI":"10.4088\/JCP.12m08186","volume":"74","author":"CH Chen","year":"2013","unstructured":"Chen CH, Huang MC, Kao CF, Lin SK, Kuo PH, Chiu CC, et al. Effects of adjunctive metformin on metabolic traits in nondiabetic clozapine-treated patients with schizophrenia and the effect of metformin discontinuation on body weight: a 24-week, randomized, double-blind, placebo-controlled study. J Clin Psychiatry. 2013;74:e424\u201330.","journal-title":"J Clin Psychiatry"},{"key":"2616_CR25","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.schres.2015.09.003","volume":"169","author":"C Shi","year":"2015","unstructured":"Shi C, Kang L, Yao S, Ma Y, Li T, Liang Y, et al. The MATRICS Consensus Cognitive Battery (MCCB): co-norming and standardization in China. Schizophr Res. 2015;169:109\u201315.","journal-title":"Schizophr Res"},{"key":"2616_CR26","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.schres.2019.01.034","volume":"208","author":"C Shi","year":"2019","unstructured":"Shi C, Kang L, Yao S, Ma Y, Li T, Liang Y, et al. What is the optimal neuropsychological test battery for schizophrenia in China? Schizophr Res. 2019;208:317\u201323.","journal-title":"Schizophr Res"},{"key":"2616_CR27","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.1093\/cercor\/bhw157","volume":"26","author":"L Fan","year":"2016","unstructured":"Fan L, Li H, Zhuo J, Zhang Y, Wang J, Chen L, et al. The human brainnetome atlas: a new brain atlas based on connectional architecture. Cereb Cortex. 2016;26:3508\u201326.","journal-title":"Cereb Cortex"},{"key":"2616_CR28","doi-asserted-by":"crossref","first-page":"e0259677","DOI":"10.1371\/journal.pone.0259677","volume":"16","author":"M Noguchi-Shinohara","year":"2021","unstructured":"Noguchi-Shinohara M, Koike M, Morise H, Kudo K, Tsuchimine S, Komatsu J, et al. MEG activity of the dorsolateral prefrontal cortex during optic flow stimulations detects mild cognitive impairment due to Alzheimer\u2019s disease. PLoS One. 2021;16:e0259677.","journal-title":"PLoS One"},{"key":"2616_CR29","doi-asserted-by":"crossref","first-page":"398","DOI":"10.2337\/dc21-1136","volume":"45","author":"S Kullmann","year":"2022","unstructured":"Kullmann S, Hummel J, Wagner R, Dannecker C, Vosseler A, Fritsche L, et al. Empagliflozin improves insulin sensitivity of the hypothalamus in humans with prediabetes: a randomized, double-blind, placebo-controlled, phase 2 trial. Diabetes Care. 2022;45:398\u2013406.","journal-title":"Diabetes Care"},{"key":"2616_CR30","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1093\/schbul\/sbv167","volume":"42","author":"S Leucht","year":"2016","unstructured":"Leucht S, Samara M, Heres S, Davis JM. Dose equivalents for antipsychotic drugs: the DDD method. Schizophr Bull. 2016;42:S90\u20134.","journal-title":"Schizophr Bull"},{"key":"2616_CR31","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1038\/npp.2015.176","volume":"40","author":"RS Keefe","year":"2015","unstructured":"Keefe RS, Meltzer HA, Dgetluck N, Gawryl M, Koenig G, Moebius HJ, et al. Randomized, double-blind, Placebo-controlled study of Encenicline, an alpha7 nicotinic acetylcholine receptor agonist, as a treatment for cognitive impairment in Schizophrenia. Neuropsychopharmacology. 2015;40:3053\u201360.","journal-title":"Neuropsychopharmacology"},{"key":"2616_CR32","doi-asserted-by":"crossref","first-page":"e13277","DOI":"10.1111\/acel.13277","volume":"20","author":"M Kodali","year":"2021","unstructured":"Kodali M, Attaluri S, Madhu LN, Shuai B, Upadhya R, Gonzalez JJ, et al. Metformin treatment in late middle age improves cognitive function with alleviation of microglial activation and enhancement of autophagy in the hippocampus. Aging Cell. 2021;20:e13277.","journal-title":"Aging Cell"},{"key":"2616_CR33","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/neurintsurg-2014-011612","volume":"8","author":"M Scherr","year":"2016","unstructured":"Scherr M, Kunz A, Doll A, Mutzenbach JS, Broussalis E, Bergmann HJ, et al. Ignoring floor and ceiling effects may underestimate the effect of carotid artery stenting on cognitive performance. J Neurointerv Surg. 2016;8:747\u201351.","journal-title":"J Neurointerv Surg"},{"key":"2616_CR34","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2337\/diacare.29.02.06.dc05-1626","volume":"29","author":"CM Ryan","year":"2006","unstructured":"Ryan CM, Freed MI, Rood JA, Cobitz AR, Waterhouse BR, Strachan MW. Improving metabolic control leads to better working memory in adults with type 2 diabetes. Diabetes Care. 2006;29:345\u201351.","journal-title":"Diabetes Care"},{"key":"2616_CR35","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1002\/pon.5129","volume":"28","author":"SJ Hartman","year":"2019","unstructured":"Hartman SJ, Nelson SH, Marinac CR, Natarajan L, Parker BA, Patterson RE. The effects of weight loss and metformin on cognition among breast cancer survivors: Evidence from the reach for health study. Psychooncology. 2019;28:1640\u20136.","journal-title":"Psychooncology"},{"key":"2616_CR36","doi-asserted-by":"crossref","first-page":"101009","DOI":"10.1016\/j.yfrne.2022.101009","volume":"66","author":"OR Ghosh-Swaby","year":"2022","unstructured":"Ghosh-Swaby OR, Reichelt AC, Sheppard PAS, Davies J, Bussey TJ, Saksida LM. Metabolic hormones mediate cognition. Front Neuroendocrinol. 2022;66:101009.","journal-title":"Front Neuroendocrinol"},{"key":"2616_CR37","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1152\/jn.90355.2008","volume":"100","author":"JL Vincent","year":"2008","unstructured":"Vincent JL, Kahn I, Snyder AZ, Raichle ME, Buckner RL. Evidence for a frontoparietal control system revealed by intrinsic functional connectivity. J Neurophysiol. 2008;100:3328\u201342.","journal-title":"J Neurophysiol"},{"key":"2616_CR38","doi-asserted-by":"crossref","first-page":"893955","DOI":"10.3389\/fnbeh.2022.893955","volume":"16","author":"Q Li","year":"2022","unstructured":"Li Q, Fu Y, Liu C, Meng Z. Transcranial direct current stimulation of the dorsolateral prefrontal cortex for treatment of neuropsychiatric disorders. Front Behav Neurosci. 2022;16:893955.","journal-title":"Front Behav Neurosci"},{"key":"2616_CR39","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41380-018-0231-1","volume":"24","author":"JY Guo","year":"2019","unstructured":"Guo JY, Ragland JD, Carter CS. Memory and cognition in schizophrenia. Mol Psychiatry. 2019;24:633\u201342.","journal-title":"Mol Psychiatry"},{"key":"2616_CR40","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.schres.2013.05.005","volume":"148","author":"TW Su","year":"2013","unstructured":"Su TW, Lan TH, Hsu TW, Biswal BB, Tsai PJ, Lin WC, et al. Reduced neuro-integration from the dorsolateral prefrontal cortex to the whole brain and executive dysfunction in schizophrenia patients and their relatives. Schizophr Res. 2013;148:50\u20138.","journal-title":"Schizophr Res"},{"key":"2616_CR41","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.biopsych.2022.09.029","volume":"94","author":"V Menon","year":"2022","unstructured":"Menon V, Palaniyappan L, Supekar K. Integrative brain network and salience models of psychopathology and cognitive dysfunction in Schizophrenia. Biol Psychiatry. 2022;94:108\u201320.","journal-title":"Biol Psychiatry"},{"key":"2616_CR42","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1126\/science.280.5364.747","volume":"280","author":"CS Carter","year":"1998","unstructured":"Carter CS, Braver TS, Barch DM, Botvinick MM, Noll D, Cohen JD. Anterior cingulate cortex, error detection, and the online monitoring of performance. Science. 1998;280:747\u20139.","journal-title":"Science"},{"key":"2616_CR43","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1001\/jamapsychiatry.2017.2663","volume":"74","author":"SP Brugger","year":"2017","unstructured":"Brugger SP, Howes OD. Heterogeneity and homogeneity of regional brain structure in schizophrenia: a meta-analysis. JAMA Psychiatry. 2017;74:1104\u201311.","journal-title":"JAMA Psychiatry"},{"key":"2616_CR44","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/schbul\/sbu126","volume":"41","author":"W Guo","year":"2015","unstructured":"Guo W, Liu F, Liu J, Yu L, Zhang J, Zhang Z, et al. Abnormal causal connectivity by structural deficits in first-episode, drug-naive schizophrenia at rest. Schizophr Bull. 2015;41:57\u201365.","journal-title":"Schizophr Bull"},{"key":"2616_CR45","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/scan\/nsx083","volume":"13","author":"M Comte","year":"2018","unstructured":"Comte M, Zendjidjian XY, Coull JT, Cancel A, Boutet C, Schneider FC, et al. Impaired cortico-limbic functional connectivity in schizophrenia patients during emotion processing. Soc Cogn Affect Neurosci. 2018;13:381\u201390.","journal-title":"Soc Cogn Affect Neurosci"},{"key":"2616_CR46","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1038\/npp.2015.119","volume":"40","author":"SL Fryer","year":"2015","unstructured":"Fryer SL, Roach BJ, Ford JM, Turner JA, van Erp TG, Voyvodic J, et al. Relating intrinsic low-frequency BOLD cortical oscillations to cognition in Schizophrenia. Neuropsychopharmacology. 2015;40:2705\u201314.","journal-title":"Neuropsychopharmacology"},{"key":"2616_CR47","doi-asserted-by":"crossref","first-page":"117557","DOI":"10.1016\/j.neuroimage.2020.117557","volume":"226","author":"M Domic-Siede","year":"2021","unstructured":"Domic-Siede M, Irani M, Vald\u00e9s J, Perrone-Bertolotti M, Ossand\u00f3n T. Theta activity from frontopolar cortex, mid-cingulate cortex and anterior cingulate cortex shows different roles in cognitive planning performance. Neuroimage. 2021;226:117557.","journal-title":"Neuroimage"},{"key":"2616_CR48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.adms.2018.09.002","volume":"6","author":"A Touroutoglou","year":"2019","unstructured":"Touroutoglou A, Andreano JM, Adebayo M, Lyons S, Barrett LF. Motivation in the service of allostasis: the role of anterior mid cingulate cortex. Adv Motiv Sci. 2019;6:1\u201325.","journal-title":"Adv Motiv Sci"},{"key":"2616_CR49","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S2215-0366(15)00115-7","volume":"2","author":"DC Henderson","year":"2015","unstructured":"Henderson DC, Vincenzi B, Andrea NV, Ulloa M, Copeland PM. Pathophysiological mechanisms of increased cardiometabolic risk in people with schizophrenia and other severe mental illnesses. Lancet Psychiatry. 2015;2:452\u201364.","journal-title":"Lancet Psychiatry"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-023-02616-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-023-02616-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-023-02616-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T11:07:54Z","timestamp":1700564874000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-023-02616-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,11]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2616"],"URL":"https:\/\/doi.org\/10.1038\/s41398-023-02616-x","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,11]]},"assertion":[{"value":"15 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"315"}}